重症患者肺部微生物组预测临床结局
在ICU入院24小时内对91例危重患者行微型支气管肺泡灌洗采样,采用微滴数字PCR和16S rRNA基因测序分析肺部微生物组。肺细菌负荷增高者无呼吸机天数更少(HR 0.43,95%CI 0.21-0.88),且菌群组成可预测无呼吸机天数(P=0.003),与肠道相关细菌(如毛螺菌科和肠杆菌科)相关,并伴随急性呼吸窘迫综合征。
要点
- 肺细菌负荷增高与28天内无呼吸机天数减少独立相关。
- 肺部菌群组成可预测无呼吸机天数,肠道相关细菌是关键驱动因素。
- 检测到肠道相关细菌与急性呼吸窘迫综合征存在关联。
核心结论
- 肺微生物组的关键特征(细菌负荷和肠道相关细菌富集)可预测危重患者的临床结局。
研究设计与样本
- 前瞻性观察性队列研究,在 university hospital 的ICU进行,纳入91例危重患者,入院24小时内行微型BAL采样,用微滴数字PCR和16S rRNA基因定量测序分析肺部微生物组。
主要发现
- 肺细菌负荷增高的患者无呼吸机天数更少(HR 0.43,95%CI 0.21-0.88),控制肺炎和疾病严重程度后仍显著。
- 肺部细菌群落组成可预测无呼吸机天数(P=0.003),由肠道相关细菌(如毛螺菌科和肠杆菌科)的存在驱动。
- 检测到肠道相关细菌与急性呼吸窘迫综合征的存在相关。
临床怎么用
- 对危重患者入院早期评估肺部微生物组特征(细菌负荷、肠道相关细菌)可能有助于风险分层。
- 肺微生物组有望成为预防和治疗急性呼吸衰竭的新靶点。
局限性
- 研究为单中心观察性队列,样本量有限,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Recent studies have revealed that, in critically ill patients, lung microbiota are altered and correlate with alveolar inflammation. The clinical significance of altered lung bacteria in critical illness is unknown.Objectives: To determine if clinical outcomes of critically ill patients are predicted by features of the lung microbiome at the time of admission.Methods: We performed a prospective, observational cohort study in an ICU at a university hospital. Lung microbiota were quantified and characterized using droplet digital PCR and bacterial 16S ribosomal RNA gene quantification and sequencing. Primary predictors were the bacterial burden, community diversity, and community composition of lung microbiota. The primary outcome was ventilator-free days, determined at 28 days after admission.Measurements and Main Results: Lungs of 91 critically ill patients were sampled using miniature BAL within 24 hours of ICU admission. Patients with increased lung bacterial burden had fewer ventilator-free days (hazard ratio, 0.43; 95% confidence interval, 0.21-0.88), which remained significant when the analysis was controlled for pneumonia and severity of illness. The community composition of lung bacteria predicted ventilator-free days (P = 0.003), driven by the presence of gut-associated bacteria (e.g., species of the Lachnospiraceae and Enterobacteriaceae families). Detection of gut-associated bacteria was also associated with the presence of acute respiratory distress syndrome.Conclusions: Key features of the lung microbiome (bacterial burden and enrichment with gut-associated bacteria) predict outcomes in critically ill patients. The lung microbiome is an understudied source of clinical variation in critical illness and represents a novel therapeutic target for the prevention and treatment of acute respiratory failure.
引用
- Dickson RP, Schultz MJ, van der Poll T, et al. Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients. Am J Respir Crit Care Med. 2020. PMID: 31973575. doi:10.1164/rccm.201907-1487OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。